EZH2 and gastric cancer: Ou et al. [69] demonstrated that EZH2 interacted with LINC00152 in GC to enhance C-X-C motif chemokine ligand 9 (CXCL9) and CXCL10 expression, ultimately suppressing CD8+ T cell infiltration.